MBX Biosciences, Inc. (MBX)

NASDAQ

$48.94

$-3.01

(-5.79%)

After-Hours

MBX Biosciences, Inc. (MBX) Live Price Chart

Last updated: ⁦2026-10-13 22:22:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

MBX Biosciences, Inc. (MBX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $48.94, with a market capitalisation of $2.56B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.94 to $72.64. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.56B
Open	$52.04
Day's High	$72.64
Day's Low	$4.81
Previous Close	$52.02
Volume	667.99K
Average Volume	521.25K
P/E Ratio	--
52-Week High	$72.64
52-Week Low	$12.94
Dividend Yield	--
Earnings Date	--

MBX Biosciences, Inc. (MBX) After-Hours Stock Price

MBX Biosciences, Inc. (MBX) is trading at $49.64 in after-hours trading as of 2026-10-13 22:19:00, down 4.57% ($2.38) from the regular-session close of $52.02.

After-hours trading shows how investors are pricing MBX after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

MBX Biosciences, Inc. (MBX) 7-Day Stock Price Change

Over the past seven days, MBX Biosciences, Inc. (MBX) moved from $58.51 to $48.94, representing a decline of 16.36% ($9.57).

The stock traded between $48.93 and $61.12 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 555.50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

MBX 52-Week Price Position

Position in Range: 60.3%

52W Low$12.94

52W High$72.64

MBX is currently trading at $48.94, placing it 60.3% of the way from its 52-week low of $12.94 to its 52-week high of $72.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is MBX Biosciences, Inc. (MBX)?

MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.

MBX Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	63
Exchange	NASDAQ
Company Website	https://www.mbxbio.com

How to Buy MBX Biosciences, Inc. (MBX) Stock on MEXC

Eligible investors can buy real shares of MBX Biosciences, Inc. (MBX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MBX and Place Your Order

Open the RealStocks trading page and search for MBX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is MBX Biosciences, Inc. (MBX) stock price today?

MBX Biosciences, Inc. (MBX) is currently trading at $ 48.94, down 5.92% ($3.08) from the previous close of $ 52.02. Intraday prices update in real time during regular trading hours.

2.Is MBX stock going up or down today?

As of 2026-10-13 22:19:00, MBX is trading at $ 48.94, down 5.92% ($3.08) from its previous close of $ 52.02. The stock has traded between $ 4.81 and $ 72.64 during today’s regular session. Past price movements do not guarantee future results.

3.What is MBX pre-market price?

As of 2026-10-13 22:19:00, MBX is trading at $ 52.19 in pre-market trading, up 0.33% ($0.17) from the previous close of $ 52.02. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MBX after-hours price?

As of 2026-10-13 22:19:00, MBX is trading at $ 49.64 in after-hours trading, down 4.57% ($2.38) from the regular-session close of $ 52.02. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MBX stock trading now?

MBX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MBX sit relative to its 52-week high and low?

Over the past 52 weeks, MBX has traded between a low of $ 12.94 and a high of $ 72.64. At $ 48.94, the stock is positioned 60.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is MBX Biosciences, Inc. in?

MBX Biosciences, Inc. (MBX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is MBX Biosciences, Inc.'s market capitalisation and where is it listed?

MBX Biosciences, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2.56B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MBX valued in terms of P/E ratio and EPS?

MBX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does MBX Biosciences, Inc. pay a dividend?

MBX Biosciences, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.